These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 24788150)

  • 41. The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line.
    Chen YY; Shuang B; Tan YX; Meng MJ; Han P; Mo XN; Song QS; Qiu XY; Luo X; Gan QN; Zhang X; Zheng Y; Liu SA; Wang XN; Zhong NS; Ma DL
    Chin Med J (Engl); 2005 Feb; 118(4):267-74. PubMed ID: 15740663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.
    Eckerle LD; Becker MM; Halpin RA; Li K; Venter E; Lu X; Scherbakova S; Graham RL; Baric RS; Stockwell TB; Spiro DJ; Denison MR
    PLoS Pathog; 2010 May; 6(5):e1000896. PubMed ID: 20463816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
    Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species.
    Niemeyer D; Mösbauer K; Klein EM; Sieberg A; Mettelman RC; Mielech AM; Dijkman R; Baker SC; Drosten C; Müller MA
    PLoS Pathog; 2018 Sep; 14(9):e1007296. PubMed ID: 30248143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
    Yi CE; Ba L; Zhang L; Ho DD; Chen Z
    J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
    Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
    J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.
    Jimenez-Guardeño JM; Regla-Nava JA; Nieto-Torres JL; DeDiego ML; Castaño-Rodriguez C; Fernandez-Delgado R; Perlman S; Enjuanes L
    PLoS Pathog; 2015 Oct; 11(10):e1005215. PubMed ID: 26513244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function.
    Chan CM; Tsoi H; Chan WM; Zhai S; Wong CO; Yao X; Chan WY; Tsui SK; Chan HY
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2232-9. PubMed ID: 19398035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
    Sekimukai H; Iwata-Yoshikawa N; Fukushi S; Tani H; Kataoka M; Suzuki T; Hasegawa H; Niikura K; Arai K; Nagata N
    Microbiol Immunol; 2020 Jan; 64(1):33-51. PubMed ID: 31692019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS coronavirus replicase proteins in pathogenesis.
    Graham RL; Sparks JS; Eckerle LD; Sims AC; Denison MR
    Virus Res; 2008 Apr; 133(1):88-100. PubMed ID: 17397959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronavirus Proteins as Ion Channels: Current and Potential Research.
    McClenaghan C; Hanson A; Lee SJ; Nichols CG
    Front Immunol; 2020; 11():573339. PubMed ID: 33154751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS coronavirus E protein forms cation-selective ion channels.
    Wilson L; McKinlay C; Gage P; Ewart G
    Virology; 2004 Dec; 330(1):322-31. PubMed ID: 15527857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
    Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
    Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.
    de Haan CA; Rottier PJ
    Cell Microbiol; 2006 Aug; 8(8):1211-8. PubMed ID: 16803585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody.
    Ng OW; Keng CT; Leung CS; Peiris JS; Poon LL; Tan YJ
    PLoS One; 2014; 9(7):e102415. PubMed ID: 25019613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.
    Roberts A; Deming D; Paddock CD; Cheng A; Yount B; Vogel L; Herman BD; Sheahan T; Heise M; Genrich GL; Zaki SR; Baric R; Subbarao K
    PLoS Pathog; 2007 Jan; 3(1):e5. PubMed ID: 17222058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.
    Madu IG; Roth SL; Belouzard S; Whittaker GR
    J Virol; 2009 Aug; 83(15):7411-21. PubMed ID: 19439480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.
    Bolles M; Deming D; Long K; Agnihothram S; Whitmore A; Ferris M; Funkhouser W; Gralinski L; Totura A; Heise M; Baric RS
    J Virol; 2011 Dec; 85(23):12201-15. PubMed ID: 21937658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.